-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

623.O2.6 623. Mantle Cell, Follicular, and Other Indolent B Cell Lymphomas: Clinical and Epidemiological II

Symposia: Mantle Cell, Follicular, and Other Indolent B Cell Lymphomas: Clinical and Epidemiological Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, clinical trials, Biological therapies, epidemiology, Lymphomas, non-Hodgkin lymphoma, Non-Biological therapies, Bispecific Antibody Therapy, Clinical Research, B Cell lymphoma, Chemotherapy, Combination therapy, Diseases, indolent lymphoma, Therapies, Immunotherapy, real-world evidence, Lymphoid Malignancies, Adverse Events, registries, Monoclonal Antibody Therapy, Technology and Procedures, Study Population, Human, Minimal Residual Disease , machine learning
Monday, December 12, 2022: 4:30 PM-6:00 PM
R06-R09 (Ernest N. Morial Convention Center)
Moderators:
Sumana Devata, MD, Medical College of Wisconsin and Narendranath Epperla, MD, MS, The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute
Disclosures:
Epperla: Incyte: Speakers Bureau; Novartis: Honoraria; TG Therapeutics: Other: Ad Board; BeiGene: Other: Ad Board; Seattle Genetics: Other: Ad Board; Pharmacyclics: Other: Ad Board.
This session focuses on the studies (both clinical and epidemiological) studies pertaining to follicular lymphoma
4:30 PM

Tae Min Kim, MD, PhD1*, Michal Taszner, MD2*, Seok-Goo Cho, M.D., Ph.D.3*, Silvana Novelli, MD, PhD4, Steven Le Gouill, MD, PhD5, Michelle Limei Poon, MBBS, MRCP6*, Jose C. Villasboas, MD7, Rebecca Champion, MD8*, Emmanuel Bachy, MD, PhD9*, Stéphanie Guidez, MD10*, Aránzazu Alonso Alonso, MD11*, Deepa Jagadeesh, MD12, Michele Merli, MD13*, David Tucker, MD14*, Jingxian Cai15*, Carolina Leite De Oliveira, PharmD15*, Min Zhu, PhD15*, Aafia Chaudhry, MD, MBA, MS15*, Hesham Mohamed, MD15*, Srikanth R. Ambati, MBBS, MD15* and Stefano Luminari, MD16

1Seoul National University Hospital, Seoul, Korea, Republic of (South)
2Uniwersyteckie Centrum Kliniczne Klinika Hematologii I Transplantologii, Gdańsk, Poland
3The Catholic University of Korea, Seoul St. Mary’s Hospital Hematology, Seoul, Korea, Republic of (South)
4Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
5Hospital Group at Institute Curie, Paris, France
6Hematology Oncology National University Hospital, Singapore, Singapore
7Mayo Clinic Rochester, Rochester, NY
8Norton Cancer Institute, Louisville, KY
9Hospices Civils de Lyon and Université Claude Bernard Lyon 1, Lyon, France
10Centre Hospitalier Universitaire (CHU) de Poitiers, Poitiers, France
11Hospital Universitario Quiron Salud Madrid, Madrid, Spain
12Cleveland Clinic Main Campus, Cleveland, OH
13Hematology, Ospedale di Circolo e Fondazione Macchi, Varese, Italy
14Royal Cornwall Hospital, Cornwall, United Kingdom
15Regeneron Pharmaceuticals, Inc., Tarrytown, NY
16Division of Hematology, Azienda Unità Sanitaria Locale-IRCCS, Reggio Emilia, Italy

4:45 PM

Marie José Kersten, MD, PhD1, Martin Dreyling, MD2, Kim M. Linton3*, Dana Chitu, PhD4*, Sanne Tonino5*, Marcel Kap, BSc6*, Roberto D Liu, BSc7*, Martine E.D. Chamuleau, MD, PhD8, Hein P.J. Visser, MD9*, Eva De Jongh, MD10*, Erik WAF Marijt, MD, PhD11, Maria B.L. Leijs, MD12,13*, Yavuz M. Bilgin, MD PhD14*, Jan Dürig, MD15*, Pamela McKay, MBChB, FRCP, FRCPath16*, Tjeerd J.F. Snijders, MD PhD17*, Andrew Pettitt, PhD, FRCPath18,19*, Monique C. Minnema, MD, PhD20, Gabriele Prange-Krex, MD21*, Maria Cuijpers, MD22*, Lara H. Böhmer, MD23*, Lidwine W. Tick, MD, PhD24, Axel Florschütz25*, Matthijs Silbermann26*, Rob Fijnheer27*, Aart Beeker28, Nelleke Tolboom, MD29*, Cristina Mitea, MD30*, Anne IJ Arens, MD31*, Gerben JC Zwezerijnen, MD32*, Wolfram Klapper33*, Sarah E. Coupland, MBBS, PhD34*, Daphne de Jong, MD, PhD35*, Jeanette K. Doorduijn, MD, PhD36 and Josée M. Zijlstra, MD PhD37

1Amsterdam University Medical Centers, Location University of Amsterdam; Cancer Center Amsterdam, Amsterdam, Netherlands
2Department of Medicine III, Klinikum Der Universitaet Muenchen-Campus Grosshadern, Munich, Germany
3Division of Cancer Sciences, University of Manchester and the Christie Hospital, Manchester, United Kingdom
4HOVON Data Center, Erasmus MC Cancer Institute, Department of Hematology, Rotterdam, Netherlands
5Dept of Hematology, Lymmcare, Cancer Center Amsterdam, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, Netherlands
6HOVON Data center, Dept. of Hematology, ErasmusMC Cancer Institute, Rotterdam, Netherlands
7Amsterdam UMC, University of Amsterdam, Amsterdam, NLD
8Amsterdam UMC, Vrije Universiteit Amsterdam, department of Hematology, Cancer Center Amsterdam, Amsterdam, Netherlands
9Hematology, Medisch Centrum Alkmaar, Alkmaar, NLD
10Department of Hematology, Albert Schweitzer Hospital, Dordrecht, Netherlands
11Hematology, Leiden University Hospital, Leiden, Netherlands
12Maasstad Ziekenhuis, Rotterdam, Netherlands
13Maasstad Ziekenhuiis, Rotterdam, Netherlands
14Department of Internal Medicine, Admiraal de Ruijter Hospital, Goes, Netherlands
15Department of Hematology, Essen University Hospital, Essen, Germany
16Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom
17Medisch Spectrum Twente, Enschede, Netherlands
18The Clatterbridge Cancer Centre NHS Foundation Trust, Liverpool, United Kingdom
19University of Liverpool, Liverpool, United Kingdom
20Department of Hematology, University Medical Center, Utrecht, Netherlands, Utrecht, Netherlands
21Gemeinschaftspraxis Mohm/Prange-Krex, Dresden, Germany
22Viecuri Medical Centre, Venlo, NLD
23Department of Hematology, Haga Teaching Hospital, The Hague, Netherlands
24Maxima Medical Center, Veldhoven, NLD
25Hematology, Klinikum Dessau, Dessau, Germany
26Ter Gooi Hospital, HILVERSUM, NLD
27Meander Medical Center, Department of Internal Medicine, Amersfoort, Netherlands
28Spaarne Ziekenhuis, Hoofddorp, Netherlands
29Nuclear Medicine, University Medical Center Utrecht, Utrecht, Netherlands
30Nuclear Medicine, Maastricht University Medical Center, Maastricht, Netherlands
31Radboud University Medical Center, Nijmegen, NLD
32Department of Radiology and Nuclear Medicine, Amsterdam UMC, Location VUmc, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, Netherlands
33University Hospital Schleswig-Holstein, Campus Kiel, Kiel, DEU
34Pathology, University of Liverpool, Liverpool, GBR
35Amsterdam UMC, Vrije Universiteit Amsterdam, department of Pathology, Cancer Center Amsterdam, Amsterdam, Netherlands
36Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, Netherlands
37Department of Hematology, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, the Netherlands, Amsterdam, Netherlands

5:00 PM

Catherine S. Diefenbach, MD1, Brad S. Kahl, MD2, Lalita Banerjee, FRCPath3*, Andrew K. McMillan, MD4, Fiona Miall, MD, FRCPath, MRCP, BMBS5*, Javier Briones, MD, PhD6*, Raul Cordoba, MD, PhD7, John M. Burke, MD8, Jamie Hirata, PharmD9, Sunil Sharma, MPH10*, Lisa Musick, PharmD9* and Pau Abrisqueta Costa, MD, PhD11*

1Perlmutter Cancer Center at NYU Langone Health, New York, NY
2Division of Oncology, Washington University, St Louis, MO
3Oncology Centre, Maidstone and Tunbridge Wells NHS Trust, Kent, United Kingdom
4Centre for Clinical Haematology, Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom
5Department of Haematology, University Hospitals of Leicester NHS Trust, Leicester, United Kingdom
6Department of Hematology, Hospital Santa Creu i Sant Pau, Barcelona, Spain
7Fundación Jiménez Díaz University Hospital, Madrid, Spain
8Rocky Mountain Cancer Centers/US Oncology, Aurora, CO
9Genentech, Inc., South San Francisco, CA
10Syneos Health, Raleigh, NC
11Hospital Vall d’Hebron, Barcelona, Spain

5:15 PM

Christopher Melani, MD1, Rahul Lakhotia, MBBS1, Stefania Pittaluga, MD, PhD2, James D. Phelan, PhD1*, Jillian Simard, MD1, Jagan R. Muppidi, MD, PhD1*, Craig J. Thomas, PhD3*, Michele Ceribelli, PhD3*, Frances Anne Tosto, MS3*, Rafic J. Farah, MD4, Seung Tae Lee, MD, PhD5, Amynah Pradhan, CRNP-F1*, Anna Marie Juanitez, RN1*, Seth M. Steinberg, PhD6*, Elaine S. Jaffe, MD2, Mark Roschewski, MD1, Louis M. Staudt, MD, PhD1 and Wyndham H. Wilson, MD, PhD1

1Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD
2Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD
3Division of Pre-Clinical Innovation Chemistry Technologies, National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD
4UPMC Hillman Cancer Center, Pittsburgh, PA
5University of Maryland Medical Center, Baltimore, MD
6Biostatistics and Data Management Section, National Cancer Institute, National Institutes of Health, Bethesda, MD

5:30 PM

Matthew J. Maurer, DSc1, Vit K Prochazka, MD, PhD2*, Christopher R. Flowers, MD3, Lasse Hjort Jakobsen, MSc, PhD4*, Diego Villa, MD5, Caroline E. Weibull, MSc, PhD6*, Elliot J. Cahn7*, Alexandra Smith, MS7*, Herve Ghesquieres, MD, PhD8*, Robert Kridel, MD9, Maher Gandhi, MBChB PhD10, Chan Yoon Y. Cheah, MD11, Eliza Hawkes, MD12, John F. Seymour, MBBS, PhD, FRACP13, Ciara L. Freeman, MSc, FRCPath, MBBChir, MRCP14, Michael Roost Clausen, MD, PhD15*, Björn E Wahlin, MD, PhD16, Jonathan W. Friedberg, MD, MMSc17, Carla Casulo, MD18, Thomas M. Habermann, MD19, Yucai Wang, MD, PhD19, Loretta J. Nastoupil, MD20, Peter De Nully Brown, MD21, David Belada, MUDr, PhD22*, Andrea Janíková, doc., MD, PhD23*, Heidi Mocikova, MD, Ph.D.24*, Tomáš Fürst, Dr.25*, Richard Burack, MD, PhD26, Peter Martin, FRCPC, MD, MS27, Jonathon B. Cohen, MD, MS28, Izidore S. Lossos, MD29, Brad S. Kahl, MD30, Brian K. Link, MD31, Karin E. Smedby, MD, PhD32*, Laurie H. Sehn, MD, MPH33, Marek Trneny, MD34, Tarec Christoffer Christoffer El-Galaly, MD, DSc35,36 and James R. Cerhan, MD, PhD1

1Department of Quantitative Health Sciences Research, Mayo Clinic, Rochester, MN
2Department of Hemato-Oncology, Faculty of Medicine and Dentistry, University Hospital In Olomouc, Olomouc, Czech Republic
3Department of Lymphoma and Myeloma, MD Anderson Cancer Center, Houston, TX
4Department of Clinical Medicine, Aalborg University, Aalborg, Denmark
5Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada
6Division of Clinical Epidemiology, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden
7Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN
8Department of Hematology, Lyon Sud University Hospital/Hospices Civils de Lyon, Pierre Benite, France
9University Health Network, Princess Margaret Cancer Center, Toronto, ON, Canada
10Department of Haematology, Princess Alexandra Hospital, Mater Research University of Queensland, Brisbane, QLD, Australia
11Linear Clinical Research and Sir Charles Gairdner Hospital, Perth, WEA, Australia
12Department of Clinical Haematology, Austin Health, Heidelberg, VIC, Australia
13Peter MacCallum Cancer Centre, Melbourne, VIC, Australia
14Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL
15Department of Haematology, Vejle Hospital, Vejle, Denmark
16Karolinska Institute, Stockholm, Sweden
17James P. Wilmot Cancer Center, University of Rochester Medical Center, Rochester, NY
18Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY
19Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN
20The University of Texas MD Anderson Cancer Center, Houston, TX
21Department of Hematology, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark
22Charles University, Faculty of Medicine, Prague, Czech Republic
23Department of Hematology and Oncology, Faculty of Medicine, Masaryk University and University Hospital, Brno, Czech Republic
24Department of Internal Medicine, Third Faculty of Medicine, Charles University and University Hospital Kralovske Vinohrady, Prague, AE, Czech Republic
25Department of Mathematical Analysis and Applications of Mathematics, Faculty of Science, Palacký University, Olomouc, Czech Republic
26Department of Pathology and Laboratory Medicine/Hematopathology, University of Rochester Medical Center, Rochester, NY
27Meyer Cancer Center, Weill Cornell Medical College-New York Presbyterian Hospital, New York, NY
28Department of Hematology and Medical Oncology, Emory University, Atlanta, GA
29Sylvester Comprehensive Cancer Center, University of Miami School of Medicine, Miami, FL
30Division of Oncology, Washington University School of Medicine in St. Louis, Saint Louis, MO
31Division of Hematology, Oncology, and Blood & Marrow Transplantation, University of Iowa, Iowa City, IA
32Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden
33Centre for Lymphoid Cancer, Department of Medical Oncology, BC Cancer and The University of British Columbia, Vancouver, BC, Canada
341st Department of Internal Medicine - Hematology, General Hospital, Charles University, Prague, Czech Republic
35Department of Hematology and Aalborg Hospital Science and Innovation Center (AHSIC), Aalborg University Hospital, Aalborg, Denmark
36Department of Haematology, Aalborg University Hospital, Aalborg, Denmark

5:45 PM

Connie Lee Batlevi, MD, PhD1, Gilles Salles, MD, PhD2, Steven I. Park, MD3,4, Tycel J. Phillips, MD5, Jennifer E. Amengual, MD6, David Andorsky, MD7*, Philip Campbell, MB, ChB8*, Pamela McKay, MD9*, John P. Leonard, MD10, Manu Sondhi, MD, MPH11*, Yingxue Chen, PhD11*, Pamela L. Slatcher, MHS, MT, PA11*, Richard Lin, PhD, MPH11*, Attila Szanto, MD, PhD11*, Sara Abbadi, PhD11* and Franck Morschhauser, MD, PhD12*

1Lymphoma Service, Cellular Therapy Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, NEW YORK, NY
2Memorial Sloan Kettering Cancer Center, New York, NY
3Levine Cancer Institute, Atrium Health, Charlotte, NC
4Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Charlotte, NC
5University of Michigan Medical School, Ann Arbor, MI
6Columbia University Irving Medical Center, New York, NY
7Rocky Mountain Cancer Centers, Boulder, CO
8Barwon Health, University Hospital Greelong, Greelong, VIC, Australia
9Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom
10Weill Cornell Medicine, New York, NY
11Epizyme, Inc., Cambridge, MA
12Service des Maladies du Sang, CHU Lille, Lille, France

*signifies non-member of ASH